AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 44 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $598,000 | -34.8% | 1,013,616 | -40.4% | 0.24% | -6.7% |
| Q4 2016 | $917,000 | -48.5% | 1,700,000 | -15.0% | 0.25% | -38.3% |
| Q3 2016 | $1,780,000 | -7.4% | 2,000,000 | 0.0% | 0.41% | -24.9% |
| Q2 2016 | $1,922,000 | -9.7% | 2,000,000 | -13.6% | 0.55% | +16.4% |
| Q1 2016 | $2,128,000 | -27.0% | 2,313,759 | 0.0% | 0.47% | -17.3% |
| Q4 2015 | $2,915,000 | +4.1% | 2,313,759 | 0.0% | 0.57% | -18.1% |
| Q3 2015 | $2,800,000 | -30.5% | 2,313,759 | 0.0% | 0.69% | -25.3% |
| Q2 2015 | $4,026,000 | +8.0% | 2,313,759 | -10.0% | 0.93% | +17.8% |
| Q1 2015 | $3,728,000 | +72.6% | 2,570,759 | 0.0% | 0.79% | +2.7% |
| Q4 2014 | $2,160,000 | -24.3% | 2,570,759 | 0.0% | 0.76% | -30.6% |
| Q3 2014 | $2,854,000 | -39.3% | 2,570,759 | 0.0% | 1.10% | -31.1% |
| Q2 2014 | $4,704,000 | +22.4% | 2,570,759 | 0.0% | 1.60% | +20.9% |
| Q1 2014 | $3,843,000 | -18.8% | 2,570,759 | 0.0% | 1.32% | -25.3% |
| Q4 2013 | $4,730,000 | – | 2,570,759 | – | 1.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
| X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
| WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
| Caption Management, LLC | 855,200 | $701,000 | 0.04% |
| Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
| Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |